Get a job referral to Alnylam Pharmaceuticals
Massachusetts, United States
1,001-5,000 Employees
Healthcare
•Tech
Description
Alnylam Pharmaceuticals (NASDAQ: ALNY) is a biopharmaceutical company founded in 2002, focused on developing RNA interference (RNAi) therapeutics for a wide range of diseases. The company's innovative approach to gene silencing has the potential to revolutionize the treatment of genetic and rare diseases, providing new hope for patients worldwide. Alnylam is committed to advancing cutting-edge science and delivering transformative therapies to improve the lives of those in need.
Alnylam Pharmaceuticals
SVP, Clinical Research
Alnylam Pharmaceuticals
Senior Director, Product Communications
Alnylam Pharmaceuticals
Executive Assistant, IT
Alnylam Pharmaceuticals
Associate Director: Health System Medical Outcomes Science Liaison-Mid-Atlantic
Alnylam Pharmaceuticals
Principal Medical Writer
Alnylam Pharmaceuticals
Director, Patient Advocacy and Engagement
Alnylam Pharmaceuticals
Principal Scientist, Bioanalytical Sciences, Outsourcing and Vendor Management
Financials
Type
public
Annual Revenue
--
Market Cap
$37.6B+
Subscribe to Refer Me premium to get referred to your dream role at Alnylam Pharmaceuticals!
